Daily Roundup

DDR.ASX CSX.ASX KME.ASX 4DX.ASX PXA.ASX

Dicker Data delivered a stellar first half, with gross revenue climbing 14.2% to $2.1 billion, driven by technology refresh cycles and surging AI infrastructure investment. The real standout was gross profit, which jumped 23.0% to $205.6 million, pushing the margin to 9.8%. Even more impressive, EBITDA rocketed 37.3% higher to $103.5 million, while net operating profit before tax surged 50.1% to $86.4 million. The company is rewarding shareholders with a fully franked dividend of 23.0 cents per share, up 4.5% from the prior year. Looking ahead, management expects gross revenue between $4.3 billion and $4.4 billion for the full year, with profit before tax landing between $162 million and $165 million. Demand for data centre refresh, software solutions, and AI-related projects should keep the momentum going through the second half, though supply chain constraints could crimp unit volumes.

4DMedical is riding a wave of regulatory wins and commercial traction. The company secured FDA clearance for its CT:VQ technology—the first non-contrast, CT-based ventilation-perfusion imaging solution—and locked in CMS reimbursement at $650.50 per scan. Top U.S. Academic Medical Centers have already started adopting the technology, and it's now available in the European Union, United Kingdom, Canada, New Zealand, and Australia. The clinical results are compelling too: CT:VQ improved lung volume reduction surgery patient selection, with responder rates jumping from 46% to 76%. Revenue grew 21% to $7.1 million for FY26, with gross margins exceeding 90%. Strategic partnerships with AstraZeneca and GlaxoSmithKline are supporting lung health screening programs and drug development. Despite an adjusted net loss of $32.9 million—down 7% from the prior year—the company's commercial momentum is undeniable, and no dividend has been declared as the business reinvests in growth.

CleanSpace Holdings reported steady sales of $19.8 million, essentially flat year-over-year, but the company is positioning itself for future growth with the launch of AGILE, a next-generation loose-fitting powered air purifying respirator. The new product opens doors in sectors like mining and infrastructure, particularly as regulatory standards tighten globally. Gross margins held firm at 75%, and cash on hand remained stable at $10.1 million. While the company posted an operating EBITDA loss of $0.6 million, that reflects deliberate investments in R&D and sales and marketing. Management is confident about delivering compound annual revenue growth of 20% or more over the medium term. The company also announced a 10% on-market share buyback, running from September 14, 2026, to September 13, 2027, signalling confidence in its value proposition.

PEXA Group is firing on multiple cylinders. Revenue from continuing operations rose 7.2% to $27.4 million, while group revenue hit $406.9 million with EBITDA climbing 12% to $151.7 million. The group's EBITDA margin expanded by 1.7 percentage points to 37.3%, reflecting disciplined cost management. Statutory net profit after tax from continuing operations improved dramatically to $19.2 million, compared to a loss of $65.6 million in FY25. The company strengthened its balance sheet, reducing leverage to 1.0 times. In the UK, PEXA successfully delivered NatWest's digital remortgage capability ahead of schedule and completed the sale of its Digital Solutions businesses. Domestically, the company launched PEXA Clear, a new AML/CTF compliance platform designed to help Australian real estate agents, conveyancers, and legal practitioners navigate expanded AUSTRAC obligations. Record transaction volumes hit in December 2025, and the company is preparing for a New Zealand pilot launch in October 2026. No dividend was declared for FY26. For the full year, management is guiding group revenue between $385 million and $415 million, EBITDA margin between 31.5% and 33.5%, and net profit after tax between $5 million and $20 million.

Kip McGrath Education Centres is returning capital to shareholders through a proposed dividend of 6.0 cents per share. The package includes a 1.0 cent ordinary dividend and 5.0 cents in special dividends—all fully franked. The proposal is subject to shareholder approval and adoption of a new constitution, and reflects management's review of the company's capital position and shareholder feedback.